Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Treatment and prevention of stroke in children with sickle cell disease.

Treatment and prevention of stroke in children with sickle cell disease. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Treatment and prevention of stroke in children with sickle cell disease. Abstract Text:

    shyamal h mehtaShyamal H Mehta,robert j adamsRobert J Adams,

    Stroke is one of the major complications in children with sickle cell disease (SCD). Ischemic stroke is associated with small asymptomatic subcortical infarcts to large territorial lesions causing major disability. Intracranial hemorrhages may be caused by aneurysm rupture or by leakage from moyamoya vessels or venous sources. There have been no acute stroke treatment studies in SCD, but hydration and exchange transfusion are often recommended. However, there is an evidence base for primary and to some extent secondary stroke prevention. Primary prevention of stroke was demonstrated in the Stroke Prevention Trial in Sickle Cell Anemia (STOP), in which children with transcranial Doppler (TCD) mean blood flow velocities of 200 cm/second (previously shown to indicate high stroke risk) or higher were randomized to either regular blood transfusions or no transfusion. The study showed a very significant 90% reduction in first stroke with transfusion. In STOP2, discontinuing transfusions after 30 months or more (even with normal TCD) resulted in a high rate of reversion to abnormal TCD values and stroke. TCD screening of all children with SCD, and initiation and maintenance of chronic transfusion to maintain hemoglobin S below 30% in the high-risk group, is the only proven prevention strategy for stroke in SCD. Hydroxyurea is being studied as secondary stroke prevention at this time. No recommendation specific to SCD regarding the use of antiplatelet agents or anticoagulants in ischemic stroke can be made. Bone marrow transplantation can be curative for SCD, and limited data support its use to prevent stroke in SCD.

    Treatment and prevention of stroke in children with sickle cell disease. Publishing Authors By Initials

    sh mehtaSH Mehta,rj adamsRJ Adams,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Treatment and prevention of stroke in children with sickle cell disease. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Current treatment options in neurology

    VOLUME: 8

    Page Numbers: 503-12

    Journal Abbreviation:

    ISSN: 1092-8480

    DAY: 11

    MONTH: Nov

    YEAR: 2006

    Treatment and prevention of stroke in children with sickle cell disease. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9815940

    Treatment and prevention of stroke in children with sickle cell disease. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Treatment and prevention of stroke in children with sickle cell disease. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Treatment and prevention of stroke in children with sickle cell disease.

    AFFILIATION: Department of Neurology, Medical College of Georgia, 1120 15th Street, Augusta, GA 30912, USA. rjadams@mcg.edu.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Curr Treat Options Neurol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Treatment and prevention of stroke in children with sickle cell disease Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News